MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, FGEN made $1,076K in revenue. $200,636K in net income. Net profit margin of 18646.47%.

Income Overview

Revenue
$1,076K
Net Income
$200,636K
Net Profit Margin
18646.47%
EPS
$49.61
Unit: Thousand (K) dollars
Revenue Breakdown
    • Drug Product Revenue
    • Development And Other Revenue

Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-09-30
Total revenue
1,076 1,348 2,739 46,333
Cost of goods sold
-58 85 252 5,295
Research and development
1,209 5,865 9,175 21,708
Selling, general and administrative
5,295 7,057 8,106 17,554
Restructuring charge
41 393 126 18,554
Total operating costs and expenses
6,487 13,400 17,659 63,111
Loss from operations
-5,411 -12,052 -14,920 -16,778
Interest expense
2,083 2,009 2,257 4,994
Loss on debt extinguishments
-6,583 ---
Interest income and other income (expenses), net
931 286 413 3,802
Total interest and other, net
-7,735 -1,723 -1,844 -1,192
Loss from continuing operations before income taxes
-13,146 -13,775 -16,764 -17,970
Investment income (loss)
---898
Provision for (benefit from) income taxes
0 -92 2 12
Loss from continuing operations
-13,146 -13,683 -16,766 -
Product revenue, net
167,179 ---
Cost of goods sold
3,761 ---
Research and development
438 ---
Selling, general and administrative
1,311 ---
Total operating costs and expenses
5,510 ---
Income from operations
161,669 ---
Interest expense
1,900 ---
Gain on divestiture
52,163 ---
Interest income and other income (expenses), net
-475 ---
Total interest and other, net
-50,738 ---
Income before income taxes
212,407 ---
Provision for income taxes
0 ---
Investment income in unconsolidated variable interest entity
-1,375 ---
Income from discontinued operations, net of tax
213,782 6,080 21,405 -
Net income (loss)
200,636 -7,603 4,639 -17,084
Basic EPS
49.61 -1.88 0.05 -0.17
Diluted EPS
49.61 -1.88 0.05 -0.17
Basic Average Shares
4,044,000 4,042,000 100,954,000 100,515,000
Diluted Average Shares
4,044,000 4,042,000 100,954,000 100,515,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Product revenue, net$167,179K Gain on divestiture$52,163K Interest income and otherincome (expenses), net-$475K (-112.49%↓ Y/Y)Income from operations$161,669K Total interest andother, net-$50,738K (-4156.54%↓ Y/Y)Total operating costsand expenses$5,510K (-91.27%↓ Y/Y)Interest expense$1,900K (-61.95%↓ Y/Y)Income before incometaxes$212,407K Investment income inunconsolidated variable...-$1,375K Cost of goods sold$3,761K (-28.97%↓ Y/Y)Selling, general andadministrative$1,311K (-92.53%↓ Y/Y)Research and development$438K (-97.98%↓ Y/Y)Income fromdiscontinued operations, net...$213,782K Net income (loss)$200,636K (1274.41%↑ Y/Y)Loss from continuingoperations-$13,146K Loss from continuingoperations before income...-$13,146K (26.84%↑ Y/Y)Drug Product Revenue$957K Development And OtherRevenue$119K Total interest andother, net-$7,735K (-548.91%↓ Y/Y)Loss from operations-$5,411K (67.75%↑ Y/Y)Interest income and otherincome (expenses), net$931K (-75.51%↓ Y/Y)Total revenue$1,076K (-97.68%↓ Y/Y)Loss on debtextinguishments-$6,583K Interest expense$2,083K (-58.29%↓ Y/Y)Total operating costsand expenses$6,487K (-89.72%↓ Y/Y)Cost of goods sold-$58K (-101.10%↓ Y/Y)Selling, general andadministrative$5,295K (-69.84%↓ Y/Y)Research and development$1,209K (-94.43%↓ Y/Y)Restructuring charge$41K (-99.78%↓ Y/Y)

FIBROGEN INC (FGEN)

FIBROGEN INC (FGEN)